Learn languages naturally with fresh, real content!

Popular Topics
Explore By Region
The FDA has reviewed the first module of Implantica AG's application for RefluxStop™, an anti-reflux device.
The FDA has accepted and completed its review of Module 1 of Implantica AG's PMA application for RefluxStop™, a device aimed at treating acid reflux.
This module included quality systems and manufacturing details.
Before final approval, the FDA will inspect production sites to ensure compliance.
RefluxStop™, already CE-marked in Europe, aims to revolutionize anti-reflux treatment options.
2 months ago
5 Articles